BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22634604)

  • 1. Inhibition kinetics and regulation of sphingosine kinase 1 expression in prostate cancer cells: functional differences between sphingosine kinase 1a and 1b.
    Lim KG; Tonelli F; Berdyshev E; Gorshkova I; Leclercq T; Pitson SM; Bittman R; Pyne S; Pyne NJ
    Int J Biochem Cell Biol; 2012 Sep; 44(9):1457-64. PubMed ID: 22634604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sphingosine kinase 1 inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole induces proteasomal degradation of sphingosine kinase 1 in mammalian cells.
    Loveridge C; Tonelli F; Leclercq T; Lim KG; Long JS; Berdyshev E; Tate RJ; Natarajan V; Pitson SM; Pyne NJ; Pyne S
    J Biol Chem; 2010 Dec; 285(50):38841-52. PubMed ID: 20926375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cells.
    Tonelli F; Lim KG; Loveridge C; Long J; Pitson SM; Tigyi G; Bittman R; Pyne S; Pyne NJ
    Cell Signal; 2010 Oct; 22(10):1536-42. PubMed ID: 20570726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-AI prostate cancer cells.
    McNaughton M; Pitman M; Pitson SM; Pyne NJ; Pyne S
    Oncotarget; 2016 Mar; 7(13):16663-75. PubMed ID: 26934645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sphingosine kinase inhibitor 2-(p-hyroxyanilino)-4-(p-chlorophenyl)thiazole reduces androgen receptor expression via an oxidative stress-dependent mechanism.
    Tonelli F; Alossaimi M; Williamson L; Tate RJ; Watson DG; Chan E; Bittman R; Pyne NJ; Pyne S
    Br J Pharmacol; 2013 Mar; 168(6):1497-505. PubMed ID: 23113536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FTY720 analogues as sphingosine kinase 1 inhibitors: enzyme inhibition kinetics, allosterism, proteasomal degradation, and actin rearrangement in MCF-7 breast cancer cells.
    Lim KG; Tonelli F; Li Z; Lu X; Bittman R; Pyne S; Pyne NJ
    J Biol Chem; 2011 May; 286(21):18633-40. PubMed ID: 21464128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of sphingosine kinase 1 and 2 in regulating the metabolome and survival of prostate cancer cells.
    Tonelli F; Alossaimi M; Natarajan V; Gorshkova I; Berdyshev E; Bittman R; Watson DG; Pyne S; Pyne NJ
    Biomolecules; 2013 Jun; 3(2):316-33. PubMed ID: 24970170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles of sphingosine kinases 1 and 2 in regulating the Warburg effect in prostate cancer cells.
    Watson DG; Tonelli F; Alossaimi M; Williamson L; Chan E; Gorshkova I; Berdyshev E; Bittman R; Pyne NJ; Pyne S
    Cell Signal; 2013 Apr; 25(4):1011-7. PubMed ID: 23314175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1.
    Pchejetski D; Bohler T; Brizuela L; Sauer L; Doumerc N; Golzio M; Salunkhe V; Teissié J; Malavaud B; Waxman J; Cuvillier O
    Cancer Res; 2010 Nov; 70(21):8651-61. PubMed ID: 20959468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells.
    Leroux ME; Auzenne E; Evans R; Hail N; Spohn W; Ghosh SC; Farquhar D; McDonnell T; Klostergaard J
    Prostate; 2007 Nov; 67(15):1699-717. PubMed ID: 17879964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mode of action of the putative sphingosine kinase inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl) thiazole (SKI II): induction of lysosomal sphingosine kinase 1 degradation.
    Ren S; Xin C; Pfeilschifter J; Huwiler A
    Cell Physiol Biochem; 2010; 26(1):97-104. PubMed ID: 20502009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine kinase regulates voltage operated calcium channels in GH4C1 rat pituitary cells.
    Blom T; Bergelin N; Slotte JP; Törnquist K
    Cell Signal; 2006 Sep; 18(9):1366-75. PubMed ID: 16321506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asp177 in C4 domain of mouse sphingosine kinase 1a is important for the sphingosine recognition.
    Yokota S; Taniguchi Y; Kihara A; Mitsutake S; Igarashi Y
    FEBS Lett; 2004 Dec; 578(1-2):106-10. PubMed ID: 15581625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine mediates FTY720-induced apoptosis in LLC-PK1 cells.
    Lee WJ; Yoo HS; Suh PG; Oh S; Lim JS; Lee YM
    Exp Mol Med; 2004 Oct; 36(5):420-7. PubMed ID: 15557814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced up-regulation.
    Akao Y; Banno Y; Nakagawa Y; Hasegawa N; Kim TJ; Murate T; Igarashi Y; Nozawa Y
    Biochem Biophys Res Commun; 2006 Apr; 342(4):1284-90. PubMed ID: 16516161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine kinase inhibitor suppresses a Th1 polarization via the inhibition of immunostimulatory activity in murine bone marrow-derived dendritic cells.
    Jung ID; Lee JS; Kim YJ; Jeong YI; Lee CM; Baumruker T; Billlich A; Banno Y; Lee MG; Ahn SC; Park WS; Han J; Park YM
    Int Immunol; 2007 Apr; 19(4):411-26. PubMed ID: 17307797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles, regulation and inhibitors of sphingosine kinase 2.
    Neubauer HA; Pitson SM
    FEBS J; 2013 Nov; 280(21):5317-36. PubMed ID: 23638983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine 1-phosphate signalling in cancer.
    Pyne NJ; Tonelli F; Lim KG; Long JS; Edwards J; Pyne S
    Biochem Soc Trans; 2012 Feb; 40(1):94-100. PubMed ID: 22260672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SphK1 inhibitor II (SKI-II) inhibits acute myelogenous leukemia cell growth in vitro and in vivo.
    Yang L; Weng W; Sun ZX; Fu XJ; Ma J; Zhuang WF
    Biochem Biophys Res Commun; 2015 May; 460(4):903-8. PubMed ID: 25824043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP.
    Engedal N; Korkmaz CG; Saatcioglu F
    Oncogene; 2002 Feb; 21(7):1017-27. PubMed ID: 11850819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.